MB, Levis & Associates’s DexCom DXCM Stock Holding History

MB, Levis & Associates’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.76K	Hold	32	–	–	﹤0.01%	208
2026 Q2	$2.16K	Hold	32	–	–	﹤0.01%	232
2026 Q1	$2.01K	Hold	32	–	–	﹤0.01%	210
2025 Q4	$2.12K	Hold	32	–	–	﹤0.01%	219
2025 Q3	$2.15K	Hold	32	–	–	﹤0.01%	217
2025 Q2	$2.79K	Hold	32	–	–	﹤0.01%	236
2025 Q1	$2.18K	Hold	32	–	–	﹤0.01%	250
2024 Q4	$2.49K	Hold	32	–	–	﹤0.01%	253
2024 Q3	$2.14K	Hold	32	–	–	﹤0.01%	258
2024 Q2	$3.63K	Hold	32	–	–	﹤0.01%	232
2024 Q1	$4.44K	Hold	32	–	–	﹤0.01%	224
2023 Q4	$3.97K	Hold	32	–	–	﹤0.01%	223
2023 Q3	$2.99K	Hold	32	–	–	﹤0.01%	233
2023 Q2	$4.11K	Hold	32	–	–	﹤0.01%	227
2023 Q1	$3.72K	Hold	32	–	–	﹤0.01%	231
2022 Q4	$3.62K	Buy	+32	New	+$3.51K	﹤0.01%	214

Other funds holding DXCM

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return

MB, Levis & Associates's DXCM Position: Q3 2026 in Review

MB, Levis & Associates held its DexCom (DXCM) position steady in Q3 2026 at 32 shares worth $2.76K. The position accounts for ﹤0.01% of the portfolio, ranked #208.

MB, Levis & Associates first reported a position in DXCM in Q4 2022 and has held it in 16 quarters since. The position peaked at $4.44K in Q1 2024. 620 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

MB, Levis & Associates held 32 shares of DexCom worth $2.76K as of Q3 2026.
MB, Levis & Associates left its DexCom share count unchanged in Q3 2026.
DexCom made up ﹤0.01% of MB, Levis & Associates's portfolio in Q3 2026, its #208 holding.
MB, Levis & Associates first reported a position in DexCom in Q4 2022 and has held it in 16 quarters since.
MB, Levis & Associates's DexCom position peaked at $4.44K in Q1 2024.
620 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on MB, Levis & Associates's 13F filing for Q3 2026, filed 16 Oct 2026.